• 作者：C. Ochoa^a ; ^{carolinaochoa82@gmail.com} ; A. Breda^a ; J. Martí ; ^b ; P. de La Torre^b ; H. Villavicencio^a
• 关键词：Trasplante renal ; Estenosis de la arteria renal ; Angioplastia con baló ; n ; Stents endoluminales
• 刊名：Actas Urol贸gicas Espa帽olas
• 出版年：2012
• 期刊代码：pca37_02104806
• 类别：med
• 出版时间：May, 2012
• 卷：36
• 期：5
• 页码：325-329
• 文件大小：611 K

Introduction

The incidence of renal artery stenosis in the transplanted kidney (TRAS) varies between 2 and 23%, being the most frequent vascular complication following renal trasplantation. The delay in diagnosis and treatment can lead to functional graft loss. Percutaneous trasluminal angioplasty with stent (PTAS) is the treatment of choice to restore kidney perfusion.

Materials and Methods

Retrospective review of renal transplant casuistic in our institution between September 2005 and August 2009. Were included patients with greater than 70%TRAS and impaired graft function, treated with PTAS. Follow-up at 3, 12 and 36 months was done with creatinine, glomerular filtration rate (GFR) and Doppler ultrasonography (DUS). Technical success was defined as correct stent placement associated with decreased flow, and clinical success as improve renal function during follow-up.

Results

Incidence of TRAS was 7.3%(22/298), 60%PTAS subsidiary. 100%technical success and 84.6%clinical success, 15.4%without changes in renal function. 84%decreases flow rate greater than 70%by DUS, and 26%up to 60%. Wave changes from type III to type II were recorded in 69%and to type I in 33%.

Conclusions

The PTAS is a safe and effective procedure for the treatment of selected TRAS patients, as it preserves vascular permeability in short and medium term, ensuring the functionality of the graft. DUS is the method of choice for diagnosis and monitoring TRAS.